Cardinal Health stock soars to all-time high of $140.69

Cardinal Health Inc (NYSE:CAH). shares have reached an unprecedented peak, touching an all-time high of $140.69, with the healthcare giant now commanding a market capitalization of $34 billion. According to InvestingPro analysis, the stock appears slightly undervalued at current levels. This milestone underscores a period of robust performance for the healthcare services and products company, which has seen its stock value surge by 37.6% over the past year, building on an impressive year-to-date return of 19.18%. The company’s commitment to shareholder value is evident in its 43-year streak of consecutive dividend payments. Investors have rallied behind Cardinal Health, buoyed by the company’s strategic growth initiatives and strong market position, which have collectively propelled the stock to new heights. The impressive one-year change reflects a growing confidence in Cardinal Health’s business model and its ability to navigate the complexities of the healthcare industry. InvestingPro has identified 12 additional investment tips for Cardinal Health, including insights about its earnings growth potential and valuation metrics - unlock these exclusive insights with an InvestingPro subscription.

In other recent news, Cardinal Health has been the focus of several significant developments. Mizuho (NYSE:MFG) Securities has raised its price target for Cardinal Health to $150, maintaining an Outperform rating. This adjustment is influenced by factors such as the anticipated earnings per share (EPS) boost from the pending acquisition of Advanced Diabetes Supply Group and the expected impact of tariffs and FDA staff reductions. Jefferies has also upgraded Cardinal Health stock from Hold to Buy, setting a new price target of $150, citing the company’s promising future earnings and management performance. This upgrade reflects optimism about the company’s long-term EPS growth target of 10-14% expected to be set during the Long Range Plan update in June 2026.

Furthermore, Cardinal Health has expanded its Board of Directors with the appointment of Robert Musslewhite and Sudhakar Ramakrishna, bringing expertise in advanced analytics and cybersecurity. These appointments align with Cardinal Health’s focus on integrating technology-driven solutions into its operations. Additionally, the healthcare sector, including Cardinal Health, is showing strong performance within the S&P 500 this year, according to BTIG’s Jonathan Krinsky. The sector is nearing a multi-month relative high, indicating potential continued strong performance. These recent developments underscore Cardinal Health’s strategic moves in the healthcare industry and its ongoing focus on innovation and growth.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.